{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:45:11Z","timestamp":1794375911864,"version":"4.9.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.waojou.2024.100985","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T13:29:51Z","timestamp":1729776591000},"page":"100985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma"],"prefix":"10.1016","volume":"17","author":[{"given":"Danilo","family":"Di Bona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Ordak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Dragonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Cognet-Sice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scurati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.waojou.2024.100985_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40413-015-0078-8","article-title":"Allergen immunotherapy on the way to product-based evaluation\u2014a WAO statement","volume":"8","author":"Bachert","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"8","key":"10.1016\/j.waojou.2024.100985_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2015.2840","article-title":"Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"175","author":"Di Bona","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.waojou.2024.100985_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2012.08.012","article-title":"Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison","volume":"130","author":"Di Bona","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.waojou.2024.100985_bib4","article-title":"Sublingual immunotherapy for allergic rhinitis","author":"Radulovic","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.waojou.2024.100985_bib5","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.waojou.2024.100985_bib6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaci.2013.02.013","article-title":"Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison","volume":"131","author":"Dretzke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100985_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaip.2014.09.018","article-title":"Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy","volume":"3","author":"Nelson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2024.100985_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100985_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5414\/ALX02331E","article-title":"Guideline on allergen immunotherapy in IgE-mediated allergic diseases","volume":"6","author":"Pfaar","year":"2022","journal-title":"Allergol Select"},{"issue":"6","key":"10.1016\/j.waojou.2024.100985_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1081-1206(10)60259-1","article-title":"Comparison of allergen immunotherapy practice patterns in the United States and Europe","volume":"103","author":"Cox","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2024.100985_bib11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2024.100985_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2024.100985_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2012.08.032","article-title":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE","volume":"130","author":"Cox","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2024.100985_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaci.2009.06.006","article-title":"Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber","volume":"124","author":"Horak","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2024.100985_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis","volume":"128","author":"Didier","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100985_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2024.100985_bib17","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.waojou.2024.100985_bib18","author":"Sch\u00fcnemann"},{"key":"10.1016\/j.waojou.2024.100985_bib19","unstructured":"The GRADE Working Group. 2004-2024, 2024. https:\/\/www.gradeworkinggroup.org\/. Accessed 20 January 2024."},{"key":"10.1016\/j.waojou.2024.100985_bib20","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 8: assessing risk of bias in a randomized trial","author":"Higgins","year":"2023"},{"key":"10.1016\/j.waojou.2024.100985_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.waojou.2024.100985_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr Clin Trials"},{"issue":"11","key":"10.1016\/j.waojou.2024.100985_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"18","key":"10.1016\/j.waojou.2024.100985_bib24","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/sim.1221","article-title":"A\u00a0graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials","volume":"21","author":"Baujat","year":"2002","journal-title":"Stat Med"},{"issue":"7109","key":"10.1016\/j.waojou.2024.100985_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.waojou.2024.100985_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.waojou.2024.100985_bib27","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2023"},{"key":"10.1016\/j.waojou.2024.100985_bib28","series-title":"Version 5.0","year":"2012"},{"key":"10.1016\/j.waojou.2024.100985_bib29","unstructured":"ProMeta [Computer software]. Version 3.0. Internovi, Cesena, Italy."},{"issue":"3","key":"10.1016\/j.waojou.2024.100985_bib30","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Wiechtbauer","year":"2010","journal-title":"J Stat Software"},{"key":"10.1016\/j.waojou.2024.100985_bib31","series-title":"GRADEpro guideline development tool [software]. McMaster university and evidence prime","author":"Gradepro","year":"2021"},{"issue":"12","key":"10.1016\/j.waojou.2024.100985_bib32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/all.12518","article-title":"The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis","volume":"69","author":"Devillier","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2024.100985_bib33","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jaip.2017.04.020","article-title":"Safety review of 5-grass pollen tablet from pooled data of clinical trials","volume":"5","author":"Casale","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.100985_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jclinepi.2021.11.026","article-title":"GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines","volume":"142","author":"Cuello-Garcia","year":"2022","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.waojou.2024.100985_bib35","first-page":"127","article-title":"5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study","volume":"6","author":"Pastorello","year":"2013","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.waojou.2024.100985_bib36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s12325-017-0535-6","article-title":"Management of grass pollen allergy with 5-grass pollen tablet: results of a 2-year real-life study","volume":"34","author":"Shah-Hosseini","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.waojou.2024.100985_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/584291","article-title":"Sublingual immunotherapy with a five-grass pollen tablet in adult patients with allergic rhinitis: an open, prospective, noninterventional, multicenter study","volume":"2015","author":"Pfaar","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.waojou.2024.100985_bib38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/pai.12298","article-title":"An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents","volume":"25","author":"Eberle","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.waojou.2024.100985_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anai.2019.04.011","article-title":"Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis","volume":"123","author":"Gerstlauer","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2024.100985_bib40","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212309","article-title":"Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain","volume":"6","author":"Antolin-Amerigo","year":"2017","journal-title":"Drugs Context"},{"key":"10.1016\/j.waojou.2024.100985_bib41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/imt-2021-0161","article-title":"Patient needs and benefits of sublingual immunotherapy for grass pollen-induced allergic rhinitis: an observational study","volume":"13","author":"Klein","year":"2021","journal-title":"Immunotherapy"},{"key":"10.1016\/j.waojou.2024.100985_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40801-017-0109-6","article-title":"Treatment satisfaction during sublingual immunotherapy with a five-grass pollen tablet for allergic rhinoconjunctivitis: a prospective, non-interventional study","volume":"4","author":"Schafer","year":"2017","journal-title":"Drugs Real World Outcomes"},{"issue":"2","key":"10.1016\/j.waojou.2024.100985_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100632","article-title":"5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: impact of sensitization to subtropical grass pollen","volume":"15","author":"Van Nunen","year":"2022","journal-title":"World Allergy Org. J"},{"key":"10.1016\/j.waojou.2024.100985_bib44","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/1744666X.2017.1398082","article-title":"Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis","volume":"13","author":"Devillier","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100985_bib45","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/all.13705","article-title":"Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France","volume":"74","author":"Devillier","year":"2019","journal-title":"Allergy"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T11:41:13Z","timestamp":1731843673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455124001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1939455124001170"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100985","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100985"}}